Found: 11
Select item for more details and to access through your institution.
Expression ratio of CCND1 to CDKN2A mRNA predicts RB1 status of cultured cancer cell lines and clinical tumor samples.
- Published in:
- Molecular Cancer, 2011, v. 10, n. 1, p. 31, doi. 10.1186/1476-4598-10-31
- By:
- Publication type:
- Article
TAS-119, a novel selective Aurora A and TRK inhibitor, exhibits antitumor efficacy in preclinical models with deregulated activation of the Myc, β-Catenin, and TRK pathways.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 3, p. 724, doi. 10.1007/s10637-020-01019-9
- By:
- Publication type:
- Article
ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells.
- Published in:
- Molecular Cancer, 2016, v. 15, p. 1, doi. 10.1186/s12943-016-0516-4
- By:
- Publication type:
- Article
Synthetic lethal interactions for the development of cancer therapeutics: biological and methodological advancements.
- Published in:
- Human Genetics, 2010, v. 128, n. 6, p. 567, doi. 10.1007/s00439-010-0900-x
- By:
- Publication type:
- Article
Muscle RAS oncogene homolog ( MRAS) recurrent mutation in Borrmann type IV gastric cancer.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 1, p. 235, doi. 10.1002/cam4.959
- By:
- Publication type:
- Article
Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
- Published in:
- International Journal of Cancer, 2004, v. 109, n. 2, p. 238, doi. 10.1002/ijc.11669
- By:
- Publication type:
- Article
Protamine-Modified DDAB Lipid Vesicles Promote Gene Transfer in the Presence of Serum1.
- Published in:
- Journal of Biochemistry, 2001, v. 129, n. 1, p. 125, doi. 10.1093/oxfordjournals.jbchem.a002822
- By:
- Publication type:
- Article
Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors.
- Published in:
- Protein Science: A Publication of the Protein Society, 2007, v. 16, n. 12, p. 2626, doi. 10.1110/ps.073123707
- By:
- Publication type:
- Article
3'-Ethynylcytidine, an RNA polymerase inhibitor, combined with cisplatin exhibits a potent synergistic growth-inhibitory effect via Vaults dysfunction.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-562
- By:
- Publication type:
- Article
TAS2940, a novel brain‐penetrable pan‐ERBB inhibitor, for tumors with HER2 and EGFR aberrations.
- Published in:
- Cancer Science, 2023, v. 114, n. 2, p. 654, doi. 10.1111/cas.15617
- By:
- Publication type:
- Article
3'-ethynylcytidine, an RNA polymerase inhibitor, combined with cisplatin exhibits a potent synergistic growth-inhibitory effect via Vaults dysfunction.
- Published in:
- 2014
- By:
- Publication type:
- journal article